Brief: Advaxis Inc Regains Compliance With Nasdaq Listing Rules - SEC Filing
16/01/2020 19:42
Jan 16 (Reuters) - Advaxis Inc ADXS.O :
* ADVAXIS INC SAYS RECEIVED NOTICE FROM NASDAQ INDICATING CO
HAS
REGAINED COMPLIANCE WITH NASDAQ LISTING RULES - SEC FILING
Source text for Eikon: bit.ly/2TuwJRt
Further company coverage: ADXS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ayala Pharmaceuticals
See all newsBrief: Ayala Pharmaceuticals Completes Sale Of AL102 To Immunome
Immunome slides on $200 mln equity offering
Immunome edges up after $200 mln equity offering
Brief: Immunome To Acquire AL102 Phase 3 Asset for the Treatment of Desmoid Tumors From Ayala Pharmaceuticals
Brief: Ayala Pharmaceuticals Announces AL102 Receives Orphan Drug Designation for Desmoid Tumors